论文部分内容阅读
目的观察伊托必利对功能性消化不良的治疗效果。方法选取医院2012年3月-2013年4月收治的功能性消化不良患者94例,随机分为观察组和对照组各47例,观察组患者给予伊托必利治疗,对照组给予多潘立酮治疗,比较2组患者临床治疗效果及不良反应发生情况。结果观察组总有效率为97.9%明显优于对照组的87.2%),差异有统计学意义(P<0.05)。观察组不良反应发生率为8.5%明显低于对照组的14.9%,差异有统计学意义(P<0.05)。2组患者均未出现明显的不良反应。结论伊托必利应用于功能性消化不良临床疗效显著,快速缓解患者功能性消化不良症状,提高患者的生活质量。
Objective To observe the therapeutic effect of itopride on functional dyspepsia. Methods Ninety-four patients with functional dyspepsia admitted from March 2012 to April 2013 in our hospital were randomly divided into observation group (47 cases) and control group (47 cases), treatment group (Itopride) and domperidone group The clinical effects and adverse reactions of two groups were compared. Results The total effective rate in the observation group was 97.9%, which was significantly better than that in the control group (87.2%), the difference was statistically significant (P <0.05). The incidence of adverse reactions in the observation group was 8.5%, which was significantly lower than that in the control group (14.9%), the difference was statistically significant (P <0.05). No significant adverse reactions occurred in both groups. Conclusion Itopride is effective in treating functional dyspepsia and relieving functional dyspepsia rapidly and improving the quality of life of patients.